apt-1011
Showing 1 - 4 of 4
Eosinophilic Esophagitis Trial in United States (APT-1011, Placebo oral tablet)
Recruiting
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Colorado Springs, Colorado
- +4 more
Jan 4, 2023
Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Indianapolis, Indiana
- +2 more
Nov 13, 2022
Eosinophilic Esophagitis Trial in Australia, Spain, United States (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Anniston, Alabama
- +54 more
Nov 9, 2022
Eosinophilic Esophagitis Trial in Worldwide (APT-1011, Placebo)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo
-
Chandler, Arizona
- +74 more
Jan 28, 2021